InMed Pharmaceuticals Shares Are Trading Higher After the Company Announced It Was Granted U.S. Patent US 12083229 B2 16/611837 for 'Ocular Drug Delivery Formulation'
InMed Pharmaceuticals Shares Are Trading Higher After the Company Announced It Was Granted U.S. Patent US 12083229 B2 16/611837 for 'Ocular Drug Delivery Formulation'
inmed pharmaceuticals股价上涨,因该公司宣布获得了美国专利US 12083229 B2 16/611837,用于“眼部药物给药配方”。
InMed Pharmaceuticals Shares Are Trading Higher After the Company Announced It Was Granted U.S. Patent US 12083229 B2 16/611837 for 'Ocular Drug Delivery Formulation'
inmed pharmaceuticals股价上涨,因该公司宣布获得了美国专利US 12083229 B2 16/611837,用于“眼部药物给药配方”。